D Kohoutova1,2,3, A Tringali1,4, G Papparella1, V Perri1,4, I Boškoski1,4, J Hamanaka1,5,6, G Costamagna1,4,7. 1. Digestive Endoscopy Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia. 2. The Royal Marsden NHS Foundation Trust, London, UK. 3. Charles University, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, 2nd Department of Internal Medicine - Gastroenterology, Hradec Kralove, Czech Republic. 4. Centre for Endoscopic Research Therapeutics and Training - CERTT, Università Cattolica del Sacro Cuore, Roma, Italia. 5. Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan. 6. Department of Gastroenterology, Yokohama Minami Kyosai Hospital, Yokohama, Japan. 7. Chair of Digestive Endoscopy, IHU-USIAS, University of Strasbourg, Strasbourg, France.
Abstract
Background: Chronic pancreatitis (CP) in children is an inreasingly recognized disease. Objective: The purpose of study was to analyse the safety and long-term efficacy of endoscopic treatment in children with CP. Methods: Records of 38 patients aged <18 years, referred to the Digestive Endoscopy Unit at Catholic University, Fondazione Policlinico "A. Gemelli" IRCCS between 1991 and 2017, were reviewed. Abdominal pain, analgesia and number of episodes of acute pancreatitis in the pre- and post- endoscopic retrograde cholangiopancreatography (ERCP) period were evaluated. Need for surgery was assessed. Therapeutic intervention data and complications were interrogated. Results: In total 158 ERCPs were performed. Median post-ERCP follow-up was 7 years. The majority of patients had CP type IV (47%) and type Ib (37%) (Cremer's classification). Major papilla pancreatic sphincterotomy was performed in 47%, major and minor in 24% and minor in 29% of patients. Stones/plugs were removed in at least one ERCPs in 66% individuals. Eleven out of 38 patients had stricture of the pancreatic duct; these were dilated and stented in 5/11 and stented in 6/11. Five complications were recorded (3%). Severity and frequency of abdominal pain improved significantly; p < 0.001. Use of analgesia and number of episodes of acute pancreatitis decreased significantly; p < 0.001. One child required subsequent surgery. Conclusion: Endoscopic management of symptomatic CP in children is safe and effective.
Background: Chronic pancreatitis (CP) in children is an inreasingly recognized disease. Objective: The purpose of study was to analyse the safety and long-term efficacy of endoscopic treatment in children with CP. Methods: Records of 38 patients aged <18 years, referred to the Digestive Endoscopy Unit at Catholic University, Fondazione Policlinico "A. Gemelli" IRCCS between 1991 and 2017, were reviewed. Abdominal pain, analgesia and number of episodes of acute pancreatitis in the pre- and post- endoscopic retrograde cholangiopancreatography (ERCP) period were evaluated. Need for surgery was assessed. Therapeutic intervention data and complications were interrogated. Results: In total 158 ERCPs were performed. Median post-ERCP follow-up was 7 years. The majority of patients had CP type IV (47%) and type Ib (37%) (Cremer's classification). Major papilla pancreatic sphincterotomy was performed in 47%, major and minor in 24% and minor in 29% of patients. Stones/plugs were removed in at least one ERCPs in 66% individuals. Eleven out of 38 patients had stricture of the pancreatic duct; these were dilated and stented in 5/11 and stented in 6/11. Five complications were recorded (3%). Severity and frequency of abdominal pain improved significantly; p < 0.001. Use of analgesia and number of episodes of acute pancreatitis decreased significantly; p < 0.001. One child required subsequent surgery. Conclusion: Endoscopic management of symptomatic CP in children is safe and effective.
Entities:
Keywords:
Chronic pancreatitis; ERCP; efficacy and safety; pediatric population; personalized medicine
Authors: R K Hsu; P Draganov; J W Leung; P R Tarnasky; A S Yu; R H Hawes; J T Cunningham; P B Cotton Journal: Gastrointest Endosc Date: 2000-04 Impact factor: 9.427
Authors: David C Whitcomb; Luca Frulloni; Pramod Garg; Julia B Greer; Alexander Schneider; Dhiraj Yadav; Tooru Shimosegawa Journal: Pancreatology Date: 2016-02-16 Impact factor: 3.996
Authors: Maria G Sacco Casamassima; Seth D Goldstein; Jingyan Yang; Colin D Gause; Fizan Abdullah; Avner Meoded; Martin A Makary; Paul M Colombani Journal: Pediatr Surg Int Date: 2016-11-04 Impact factor: 1.827
Authors: David M Troendle; Douglas S Fishman; Bradley A Barth; Matthew J Giefer; Tom K Lin; Quin Y Liu; Maisam Abu-El-Haija; Melena D Bellin; Peter R Durie; Steven D Freedman; Cheryl Gariepy; Tanja Gonska; Melvin B Heyman; Ryan Himes; Sohail Z Husain; Soma Kumar; Mark E Lowe; Veronique D Morinville; Chee Y Ooi; Joseph Palermo; John F Pohl; Sarah Jane Schwarzenberg; Steven Werlin; Michael Wilschanski; M Bridget Zimmerman; Aliye Uc Journal: Pancreas Date: 2017-07 Impact factor: 3.327
Authors: Emily R Perito; John F Pohl; Caitlin Bakker; Matthew A Armfield; Bradley Barth; Addison Cuneo; Maria Mascarenhas; Megha Mehta; Sarah Jane Schwarzenberg Journal: Pancreas Date: 2022-02-01 Impact factor: 3.327